EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

Bisphosphonates in combination with alendronate sodium increase bone mineral density and modulate IL-6, TNF-α, and IGF-1 in patients with osteoporosis

Xuechun Gu, Liyuan Zhang, Xiangyi Chen, Lingyan Kong

Int. Journal of Clinical Pharmacology and Therapeutics · 2025

DOI: 10.5414/cp204706 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Int. Journal of Clinical Pharmacology and Therapeutics, 2025. Verfasst von Xuechun Gu und 3 weiteren Autor:innen. Hauptthemen laut MEDLINE: Alendronate, Bone Density, Bone Density Conservation Agents, Osteoporosis. Die Arbeit wurde bisher 2-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AlendronateBone DensityBone Density Conservation AgentsOsteoporosisZoledronic AcidAgedAged, 80 and overFemaleHumansMaleMiddle AgedDrug Therapy, CombinationInsulin-Like Growth Factor IInterleukin-6Tumor Necrosis Factor-alpha

Substanzen

AlendronateBone Density Conservation AgentsIGF1 protein, humanIL6 protein, humanInsulin-Like Growth Factor IInterleukin-6Tumor Necrosis Factor-alphaZoledronic Acid

Zitieren

APA

Gu, X., Zhang, L., Chen, X., & Kong, L. (2025). Bisphosphonates in combination with alendronate sodium increase bone mineral density and modulate IL-6, TNF-α, and IGF-1 in patients with osteoporosis. Int. Journal of Clinical Pharmacology and Therapeutics. https://doi.org/10.5414/cp204706

Vancouver

Gu X, Zhang L, Chen X, Kong L. Bisphosphonates in combination with alendronate sodium increase bone mineral density and modulate IL-6, TNF-α, and IGF-1 in patients with osteoporosis. Int. Journal of Clinical Pharmacology and Therapeutics. 2025. doi:10.5414/cp204706

BibTeX
@article{Gu2025,
  author = {Gu, Xuechun and Zhang, Liyuan and Chen, Xiangyi and Kong, Lingyan},
  title = {Bisphosphonates in combination with alendronate sodium increase bone mineral density and modulate IL-6, TNF-α, and IGF-1 in patients with osteoporosis},
  journal = {Int. Journal of Clinical Pharmacology and Therapeutics},
  year = {2025},
  doi = {10.5414/cp204706}
}
Kostenlos starten →